Activin and Inhibin

Ganoderic acid TR is a broad-spectrum inhibitor against influenza neuraminidases (NAs) , particularly H5N1 and H1N1 neuraminidases. The IC 50 values of 10.9 and 4.6 μM, respectivelyForm:SolidIC50&amp: Target:IC50: 10.9 (H5N1), 4.6 μM (H1N1).

Ganoderic acid Y is a α-glucosidase inhibitor with an IC 50 of 170 μM for yeast α-glucosidase. Ganoderic acid Y inhibits enterovirus 71 (EV71) replication through blocking EV71 uncoating.In VitroGanoderic acid Y significantly inhibits the

Ganoderol B is a potent α-glucosidase inhibitor. Ganoderol B has high α-glucosidase inhibition with an IC 50 of 48.5 μg/mL (119.8 μM).Form:Solid.

Ganoderol B is a potent α-glucosidase inhibitor. Ganoderol B has high α-glucosidase inhibition with an IC 50 of 48.5 μg/mL (119.8 μM).Form:Solid.

Garsorasib is a potent inhibitor of KRAS G12C with an IC 50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer , endometrial cancer , colorectal cancer , or lung cancer (non-small cell lung cancer)

Garsorasib is a potent inhibitor of KRAS G12C with an IC 50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer , endometrial cancer , colorectal cancer , or lung cancer (non-small cell lung cancer)

Garsorasib is a potent inhibitor of KRAS G12C with an IC 50 of 10 nM. Garsorasib has the potential for the research of various cancer such as pancreatic cancer , endometrial cancer , colorectal cancer , or lung cancer (non-small cell lung cancer)

GAT211 is a cannabinoid 1 receptor (CB1R) positive allosteric modulator (PAM). GAT211 activates cAMP and β-arrestin2 with EC 50 values of 260 nM and 650 nM, respectively. GAT211 inhibits GAT211 can be used for neuropathic and/or inflammatory pain

GAT211 is a cannabinoid 1 receptor (CB1R) positive allosteric modulator (PAM). GAT211 activates cAMP and β-arrestin2 with EC 50 values of 260 nM and 650 nM, respectively. GAT211 inhibits GAT211 can be used for neuropathic and/or inflammatory pain

GAT211 is a cannabinoid 1 receptor (CB1R) positive allosteric modulator (PAM). GAT211 activates cAMP and β-arrestin2 with EC 50 values of 260 nM and 650 nM, respectively. GAT211 inhibits GAT211 can be used for neuropathic and/or inflammatory pain

GAT211 is a cannabinoid 1 receptor (CB1R) positive allosteric modulator (PAM). GAT211 activates cAMP and β-arrestin2 with EC 50 values of 260 nM and 650 nM, respectively. GAT211 inhibits GAT211 can be used for neuropathic and/or inflammatory pain

GAT211 is a cannabinoid 1 receptor (CB1R) positive allosteric modulator (PAM). GAT211 activates cAMP and β-arrestin2 with EC 50 values of 260 nM and 650 nM, respectively. GAT211 inhibits GAT211 can be used for neuropathic and/or inflammatory pain